动态犬冠状动脉血栓形成的电诱导：一种用于体内评估抗血栓药物的模型。 - Suppr

Suppr

超能文献

Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents.

作者信息

Romson J L, Haack D W, Lucchesi B R

出版信息

Thromb Res. 1980 Mar 15;17(6):841-53. doi: 10.1016/0049-3848(80)90249-2.

DOI:10.1016/0049-3848(80)90249-2

PMID:7404490

Abstract

摘要

相似文献

Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents.

Thromb Res. 1980 Mar 15;17(6):841-53. doi: 10.1016/0049-3848(80)90249-2.

Electrically induced coronary artery thrombosis in closed chest anaesthetized dogs. Evaluation of the method.

Basic Res Cardiol. 1978 Mar-Apr;73(2):241-55. doi: 10.1007/BF01906758.

Reduction of occlusive coronary artery thrombosis and myocardial ischemia by molsidomine in anesthetized dogs.

Can J Physiol Pharmacol. 1982 Aug;60(8):1104-11. doi: 10.1139/y82-159.

Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.

J Pharmacol Exp Ther. 1986 Aug;238(2):497-501.

Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.

J Pharmacol Exp Ther. 1993 Sep;266(3):1501-11.

Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation and thrombosis.

Eur J Pharmacol. 1989 Apr 25;163(2-3):253-61. doi: 10.1016/0014-2999(89)90194-5.

Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.

Thromb Res. 1985 Aug 15;39(4):399-409. doi: 10.1016/0049-3848(85)90163-x.

Correlation of plasma serotonin changes with platelet aggregation in an in vivo dog model of spontaneous occlusive coronary thrombus formation.

Circ Res. 1986 Jan;58(1):58-67. doi: 10.1161/01.res.58.1.58.

Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist.

J Am Coll Cardiol. 1984 Jun;3(6):1417-26. doi: 10.1016/s0735-1097(84)80280-6.

Effect of zomepirac on experimental coronary artery thrombosis and ischemic myocardial injury in the conscious dog.

J Cardiovasc Pharmacol. 1983 Mar-Apr;5(2):302-8. doi: 10.1097/00005344-198303000-00023.

引用本文的文献

Update on the electrolytic IVC model for pre-clinical studies of venous thrombosis.

Res Pract Thromb Haemost. 2018 Jan 31;2(2):266-273. doi: 10.1002/rth2.12074. eCollection 2018 Apr.

The P2Y1 receptor antagonist MRS2500 prevents carotid artery thrombosis in cynomolgus monkeys.

J Thromb Thrombolysis. 2016 Apr;41(3):514-21. doi: 10.1007/s11239-015-1302-7.

Induction of a chronic myocardial infarction in the laboratory animal - experimental model.

Clujul Med. 2013;86(4):334-9. Epub 2013 Nov 6.

Investigation into the optimal surgical conditions for coronary artery ligation for establishing a myocardial infarction model in mice.

Exp Ther Med. 2013 Aug;6(2):341-346. doi: 10.3892/etm.2013.1154. Epub 2013 Jun 13.

The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse.

Thromb Haemost. 2013 Jun;109(6):1158-69. doi: 10.1160/TH12-09-0711. Epub 2013 Mar 28.

Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model.

Thromb Haemost. 2010 Aug;104(2):366-75. doi: 10.1160/TH09-09-0672. Epub 2010 Jun 29.

Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796.

Br J Pharmacol. 2002 Jul;136(6):927-37. doi: 10.1038/sj.bjp.0704744.

Plasminogen activator inhibitor type-1 (part two): role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents.

J Thromb Thrombolysis. 2001 May;11(3):195-202. doi: 10.1023/a:1011952602122.

Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation.

J Clin Invest. 1997 Apr 1;99(7):1729-38. doi: 10.1172/JCI119337.

Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosis.

Br J Pharmacol. 1996 May;118(2):271-6. doi: 10.1111/j.1476-5381.1996.tb15398.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验